KANUMA (sebelipase alfa)
METABOLIC ENZYME REPLACEMNT-LYSOSOMAL ACID LIPASE DEFICIENCY · LYSOSOMAL ACID LIPASE DEFICIENCY
ALEXION PHARMAC
Drug class
Metabolic Enzyme Replacemnt-Lysosomal Acid Lipase Deficiency
The phrase metabolic enzyme replacement for lysosomal acid lipase deficiency refers to a specialized therapeutic drug category—represented clinically by the recombinant human enzyme sebelipase alfa—used as an administrative grouping in compendia rather than an established standalone pharmacological class name. Read more about Metabolic Enzyme Replacemnt-Lysosomal Acid Lipase Deficiency
1 drugs in this class 1 manufacturers
Drugs in Metabolic Enzyme Replacemnt-Lysosomal Acid Lipase Deficiency
Filter & compare in the drug finder →
Opens the drug finder with Metabolic Enzyme Replacemnt-Lysosomal Acid Lipase Deficiency preselected. Add indication or manufacturer filters there.
The phrase metabolic enzyme replacement for lysosomal acid lipase deficiency refers to a specialized therapeutic drug category—represented clinically by the recombinant human enzyme sebelipase alfa—used as an administrative grouping in compendia rather than an established standalone pharmacological class name.
Agents in this category function by directly supplying exogenous lysosomal acid lipase to cellular lysosomes via receptor-mediated endocytosis, restoring the enzymatic hydrolysis of cholesteryl esters and triglycerides.
This intervention prevents the toxic intracellular accumulation of lipids across major organ systems, reducing hepatic steatosis and improving dyslipidemia.
Consequently, its therapeutic role is specifically directed at managing the manifestations of lysosomal acid lipase deficiency across its phenotypic spectrum, which includes rapidly progressive infantile Wolman disease and later-onset cholesteryl ester storage disease in children and adults.
-
youtube.com
The phrase metabolic enzyme replacement for lysosomal acid lipase deficiency refers to a specialized therapeutic drug category—represented clinically by the recombinant human enzyme sebelipase alfa—used as an administrative grouping in compendia rather than an established standalone pharmacological class name
-
nih.gov
The phrase metabolic enzyme replacement for lysosomal acid lipase deficiency refers to a specialized therapeutic drug category—represented clinically by the recombinant human enzyme sebelipase alfa—used as an administrative grouping in compendia rather than an established standalone pharmacological class name This intervention prevents the toxic intracellular accumulation of lipids across major organ systems, reducing hepatic steatosis and improving dyslipidemia Consequently, its therapeutic rol...
-
patsnap.com
The phrase metabolic enzyme replacement for lysosomal acid lipase deficiency refers to a specialized therapeutic drug category—represented clinically by the recombinant human enzyme sebelipase alfa—used as an administrative grouping in compendia rather than an established standalone pharmacological class name Agents in this category function by directly supplying exogenous lysosomal acid lipase to cellular lysosomes via receptor-mediated endocytosis, restoring the enzymatic hydrolysis of cholest...
-
incitefulmed.com
Agents in this category function by directly supplying exogenous lysosomal acid lipase to cellular lysosomes via receptor-mediated endocytosis, restoring the enzymatic hydrolysis of cholesteryl esters and triglycerides
-
nih.gov
This intervention prevents the toxic intracellular accumulation of lipids across major organ systems, reducing hepatic steatosis and improving dyslipidemia
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.